X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11124) 11124
Book Review (1678) 1678
Publication (504) 504
Magazine Article (48) 48
Newsletter (39) 39
Book Chapter (33) 33
Conference Proceeding (26) 26
Dissertation (8) 8
Web Resource (7) 7
Book / eBook (4) 4
Government Document (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9708) 9708
index medicus (9293) 9293
ticlopidine - analogs & derivatives (8270) 8270
male (5697) 5697
ticlopidine - therapeutic use (5208) 5208
female (5058) 5058
platelet aggregation inhibitors - therapeutic use (4714) 4714
middle aged (4199) 4199
aged (3978) 3978
clopidogrel (3931) 3931
aspirin (3006) 3006
cardiac & cardiovascular systems (2794) 2794
aspirin - therapeutic use (2789) 2789
ticlopidine - administration & dosage (2774) 2774
ticlopidine - adverse effects (2495) 2495
treatment outcome (2448) 2448
platelet aggregation inhibitors - administration & dosage (2393) 2393
platelet aggregation inhibitors - adverse effects (2261) 2261
ticlopidine (2113) 2113
drug therapy, combination (2062) 2062
abridged index medicus (2014) 2014
percutaneous coronary intervention (1604) 1604
risk factors (1580) 1580
ticlopidine - pharmacology (1572) 1572
peripheral vascular disease (1519) 1519
platelet aggregation - drug effects (1515) 1515
stents (1491) 1491
aspirin - administration & dosage (1455) 1455
adult (1385) 1385
platelet aggregation inhibitors - pharmacology (1348) 1348
hematology (1263) 1263
antiplatelet therapy (1254) 1254
time factors (1224) 1224
pharmacology & pharmacy (1123) 1123
thrombosis (1068) 1068
acute coronary syndromes (1067) 1067
medicine, general & internal (1027) 1027
risk (1005) 1005
prospective studies (1001) 1001
myocardial-infarction (1000) 1000
aged, 80 and over (988) 988
aspirin - adverse effects (982) 982
blood platelets - drug effects (935) 935
drug therapy (928) 928
therapy (901) 901
stroke (884) 884
follow-up studies (842) 842
acute coronary syndrome - drug therapy (838) 838
angioplasty, balloon, coronary (837) 837
trial (806) 806
cardiovascular (799) 799
animals (771) 771
retrospective studies (771) 771
heart attacks (753) 753
prevention (725) 725
hemorrhage - chemically induced (713) 713
cardiology (711) 711
blood platelets (704) 704
care and treatment (670) 670
coronary heart disease (663) 663
myocardial infarction - drug therapy (662) 662
anticoagulants - therapeutic use (661) 661
cardiac patients (657) 657
prasugrel (654) 654
drug interactions (645) 645
surgery (644) 644
aggregation (638) 638
drug-eluting stents (629) 629
dose-response relationship, drug (614) 614
platelet function tests (613) 613
mortality (605) 605
intervention (595) 595
stent (591) 591
thrombosis - prevention & control (590) 590
angioplasty (587) 587
adenosine - analogs & derivatives (579) 579
risk assessment (578) 578
randomized controlled trials as topic (564) 564
platelets (562) 562
acute myocardial-infarction (559) 559
prasugrel hydrochloride (554) 554
analysis (546) 546
cardiovascular disease (534) 534
stroke - prevention & control (534) 534
aspirin - pharmacology (527) 527
inhibition (526) 526
ticlopidine - pharmacokinetics (524) 524
acute coronary syndrome (507) 507
coronary angiography (499) 499
double-blind method (499) 499
coronary artery disease - drug therapy (493) 493
platelet reactivity (491) 491
drug resistance (487) 487
outcomes (484) 484
stent thrombosis (472) 472
myocardial infarction - therapy (469) 469
platelet aggregation inhibitors - pharmacokinetics (464) 464
clinical neurology (463) 463
fibrinolytic agents - therapeutic use (459) 459
platelet aggregation (456) 456
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9900) 9900
German (312) 312
French (205) 205
Spanish (176) 176
Russian (135) 135
Japanese (133) 133
Chinese (97) 97
Italian (97) 97
Polish (38) 38
Dutch (21) 21
Danish (20) 20
Korean (17) 17
Turkish (17) 17
Hungarian (16) 16
Swedish (13) 13
Portuguese (11) 11
Finnish (8) 8
Norwegian (8) 8
Hebrew (7) 7
Ukrainian (7) 7
Czech (6) 6
Croatian (5) 5
Serbian (3) 3
Lithuanian (2) 2
Romanian (2) 2
Slovak (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2009, Volume 360, Issue 4, pp. 354 - 362
The antiplatelet drug clopidogrel requires activation by cytochrome P-450 (CYP) enzymes. This study shows that CYP polymorphisms that reduce clopidogrel... 
MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | STENT THROMBOSIS | HEALTHY-SUBJECTS | INCREASED RISK | PLATELET INHIBITION | ACUTE CORONARY SYNDROMES | PRASUGREL | ST-SEGMENT ELEVATION | INDIVIDUAL RESPONSIVENESS | ATHEROTHROMBOTIC EVENTS | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Area Under Curve | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Male | Cardiovascular Diseases - genetics | Angioplasty, Balloon, Coronary | Ticlopidine - adverse effects | Ticlopidine - metabolism | Cardiovascular Diseases - epidemiology | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - metabolism | Platelet Aggregation Inhibitors - therapeutic use | Stents | Platelet Aggregation Inhibitors - adverse effects | Genotype | Thrombosis - epidemiology | Combined Modality Therapy | Ticlopidine - analogs & derivatives | Polymorphism, Genetic | Randomized Controlled Trials as Topic | Cytochrome P-450 CYP2C19 | Acute Coronary Syndrome - therapy | Heterozygote | Thrombosis - genetics | Mutation | Usage | Genetic variation | Cytochrome P-450 | Physiological aspects | Causes of | Clopidogrel | Cardiovascular diseases | Health aspects | Risk factors | Studies | Cardiovascular disease | Heart attacks | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 10/2010, Volume 304, Issue 16, pp. 1821 - 1830
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
In this large clinical trial, aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of... 
ISSUES | MEDICINE, GENERAL & INTERNAL | PLACEBO | DESIGN | TICLOPIDINE | WARFARIN | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | REGIMENS | NON-INFERIORITY TRIALS | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 11, pp. 1045 - 1057
Journal Article